Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 Gains 73.55%

Wed, Oct 16, 2024 at 07:48 PM

Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ) soared at $8.4, a gain of 73.6%. On Wed, Oct 16, 2024, BDRX:NASDAQ hit a New 2-Week High of $8.4. The stock appeared on our News Catalysts scanner on Tue, Oct 15, 2024 at 07:19 PM in the 'INVESTOR UPDATE' category. From Wed, Oct 02, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Wed, Oct 16, 2024 at $10.89 with a volume of 7M+.

About Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ)

Midatech Pharma PLC is a part of the healthcare sector. As a pharmaceutical company, it focuses on commercializing and developing products in oncology and other therapeutic areas.

Top 10 Gainers:

Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
Santech Holdings Ltd ADS (STEC:NASDAQ), 646.89%
180 Life Sciences Corp. (ATNF:NASDAQ), 325.66%
Versus Systems Inc. (VS:NASDAQ), 249.56%
VS Media Holdings Limited (VSME:NASDAQ), 128.87%
ProQR Therapeutics N.V. (PRQR:NASDAQ), 122.1%
Korro Bio, Inc. (KRRO:NASDAQ), 93.66%
Wave Life Sciences Ltd. (WVE:NASDAQ), 74.07%
Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 73.55%
Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 67.63%